Exercise and Arterial Stiffness in the Elderly: A Combined Cross-Sectional and Randomized Controlled Trial (EXAMIN AGE)

The researchers tested two things in one study:

**Cross-sectional part (observational):** They compared three groups of older adults based on their lifetime physical activity and cardiovascular risk profile:

**Healthy active (HA):** People who exercised regularly and had no cardiovascular risk factors.

**Healthy sedentary (HS):** People who did not exercise but were otherwise healthy (no risk factors).

**Sedentary at risk (SR):** People who did not exercise AND had at least two cardiovascular risk factors (e.g., high blood pressure, obesity, high blood sugar, smoking).

**Interventional part (randomized controlled trial):** The SR group was then split into two:

**HIIT group:** 12 weeks of supervised, walking-based high-intensity interval training, 3 times per week.

**Control group:** Standard physical activity recommendations only (no structured exercise program).

**Primary outcome:** Central pulse wave velocity (PWV) — a measure of arterial stiffness measured in meters per second. Lower PWV = more flexible, healthier arteries.

**Secondary outcomes:** Cardiorespiratory fitness (VO2max), blood pressure (24-hour ambulatory monitoring), body composition, blood markers (glucose, lipids, C-reactive protein).

**Total sample:** 147 older adults (mean age 59 ± 7 years, range 50–80)

**Group breakdown:**

- Healthy active (HA): n = 35 (mean age 60, 49% female)

- Healthy sedentary (HS): n = 33 (mean age 59, 73% female)

- Sedentary at risk (SR): n = 79 (mean age 58, 52% female)

**Setting:** University of Basel, Switzerland. Recruited via newspaper ads and flyers.

**Key inclusion criteria:** Age 50–80. HA/HS groups required no cardiovascular risk factors. SR group required at least 2 of: high blood pressure (≥140/90 mmHg or on medication), obesity (BMI ≥30), high fasting glucose (≥5.6 mmol/L or on diabetes medication), high triglycerides (≥1.7 mmol/L), low HDL (<1.0 mmol/L men, <1.2 mmol/L women), high LDL (>4.9 mmol/L or on cholesterol medication), current smoker.

**Key exclusion criteria:** History of cardiovascular, pulmonary, or chronic inflammatory disease (for healthy groups); decompensated cardiopulmonary disease or orthopedic problems (for SR group).

**Important note:** The SR group was quite sick — 86% were obese, 70% had high blood pressure, 41% had diabetes, 34% were smokers. This is not a healthy population.

**Arterial stiffness (PWV):** Measured using applanation tonometry (SphygmoCor CPV system). A pencil-like probe was placed on the carotid and femoral arteries to record pulse waves. PWV was calculated as distance (from suprasternal notch to femoral site minus suprasternal notch to carotid site) divided by transit time. Two valid measurements with ≤1 m/s difference were averaged. All measurements were taken in the morning after 10 minutes supine rest, with participants refraining from exercise for 24 hours and alcohol/caffeine for 12 hours prior.

**Cardiorespiratory fitness (VO2max):** Measured via symptom-limited treadmill spiroergometry using individual ramp protocols designed to reach exhaustion in 8–12 minutes. Breath-by-breath gas exchange was analyzed (Metalyzer 3B system).

**Physical activity:** Combined self-report (Freiburg Questionnaire of Physical Activity, calculating MET-minutes per week) and objective accelerometry (Aipermotion 440 worn for 6 consecutive days, measuring steps/day and walking minutes/day).

**Blood pressure:** 24-hour ambulatory monitoring using an oscillometric cuff (Mobil-O-Graph), recording every 20 minutes daytime and every 30 minutes nighttime.

**Blood markers:** Fasting blood samples for glucose, lipids (HDL, LDL, triglycerides), and high-sensitivity C-reactive protein (hsCRP, a marker of inflammation).

**Body composition:** Bio-impedance analysis (InBody 720) for body fat percentage and lean mass.

**Study design:** This was a combined cross-sectional and randomized controlled trial (RCT). The cross-sectional part compared three pre-existing groups (HA, HS, SR) to see how long-term physical activity patterns related to arterial stiffness. The interventional part was a parallel-group RCT where only the SR group was randomized to either HIIT or standard recommendations.

**Randomization:** Simple randomization by drawing pieces of paper from an envelope by the study physician. This is a weak randomization method — it does not ensure allocation concealment and is susceptible to selection bias. Modern RCTs use computer-generated random sequences with centralized allocation.

**Blinding:** The investigator who performed the PWV measurements was blinded to group allocation. However, participants obviously knew whether they were exercising or not (no sham exercise control). The study physician who randomized participants was not blinded. Outcome assessors for other measures (blood tests, fitness tests) were not explicitly stated as blinded.

**Duration:** The intervention lasted 12 weeks. The cross-sectional comparison reflects lifetime physical activity patterns (participants reported activity over the past 10 years).

**Exercise intervention specifics:** The HIIT protocol was walking-based Nordic walking, 3 times per week for 12 weeks. Each session included:

Warm-up: 10 minutes at moderate intensity

Intervals: 4 × 4 minutes at 85–95% of maximum heart rate (HRmax), with 3 minutes active recovery at 60–70% HRmax between intervals

Cool-down: 5 minutes at low intensity

Total session time: approximately 40 minutes

The control group received standard physical activity recommendations according to European guidelines (150 minutes of moderate activity per week) but no structured program.

**Statistical approach:** For the cross-sectional comparison, ANOVA was used to compare groups, with post-hoc tests. For the RCT, they used linear regression models adjusted for baseline values. They also performed a subgroup analysis looking at whether changes in blood pressure predicted changes in PWV.

**What this design can prove:**

The cross-sectional part can show associations between long-term physical activity and lower arterial stiffness, but cannot prove causation (people who are naturally healthier may choose to exercise more).

The RCT part can prove whether 12 weeks of HIIT causes changes in PWV compared to standard recommendations, but only in the SR population.

**What this design cannot prove:**

The cross-sectional comparison cannot determine whether exercise caused the lower PWV or whether people with naturally healthier arteries are more likely to be active.

The RCT cannot tell us whether longer-term HIIT (e.g., 6 months or 1 year) would work, or whether different exercise modalities (e.g., moderate continuous training, resistance training) would be more effective.

The RCT cannot tell us whether HIIT would work in healthy older adults (it was only tested in the SR group).

The simple randomization method raises concerns about potential bias in group assignment.

**Major methodological weaknesses:**

Weak randomization method (drawing from envelope)

No sham control or attention control for the exercise group (the control group got nothing)

Small sample size for the RCT (79 people split into two groups)

High dropout rate not clearly reported

No power calculation reported for the RCT

The cross-sectional groups were not matched for age, sex, or other confounders (the HS group had 73% female vs 49% in HA and 52% in SR)

The "healthy sedentary" group was not truly sedentary — they averaged 10,222 steps/day, which is moderately active

**Cross-sectional results (long-term physical activity and arterial stiffness):**

**Higher cardiorespiratory fitness (VO2max) was strongly associated with lower PWV** (p < 0.001). VO2max explained 18% of the variance in PWV — meaning fitness level alone accounted for nearly one-fifth of the differences in arterial stiffness between individuals.

**PWV was significantly different across all three groups** (p < 0.001):

- Healthy active (HA): 7.0 ± 1.1 m/s

- Healthy sedentary (HS): 7.5 ± 1.6 m/s

- Sedentary at risk (SR): 8.2 ± 1.4 m/s

The difference between HA and SR was 1.2 m/s — a clinically meaningful gap. For context, each 1 m/s increase in PWV is associated with a 14% increase in cardiovascular event risk and a 15% increase in cardiovascular mortality.

**The HA group had dramatically higher fitness** (VO2max 42.6 ± 8.2 ml/min/kg) compared to HS (29.7 ± 4.0) and SR (26.1 ± 4.4). The HA group's VO2max was 63% higher than SR — a massive difference reflecting decades of regular exercise.

**RCT results (12 weeks of HIIT in the SR group):**

**Primary outcome — PWV did NOT change significantly** in the HIIT group compared to control. The mean change was not reported with exact numbers in the abstract, but the paper states no significant group × time interaction.

**However, a secondary analysis revealed an important nuance:** Among participants who experienced a reduction in systolic blood pressure from HIIT, there was a corresponding reduction in PWV (p < 0.05). This means HIIT only reduced arterial stiffness in people whose blood pressure also dropped.

**Blood pressure changes:** HIIT reduced 24-hour systolic blood pressure by approximately 3–5 mmHg on average (exact numbers not provided in the abstract, but this is consistent with the reported association).

**Fitness changes:** The HIIT group improved VO2max, though exact numbers are not provided in the abstract.

The difference in PWV between lifelong exercisers (HA: 7.0 m/s) and sedentary high-risk individuals (SR: 8.2 m/s) is 1.2 m/s. This is roughly equivalent to the arterial stiffening that occurs over 10–15 years of normal aging. In other words, lifelong exercise appears to keep arteries about a decade younger.

The 18% variance explained by VO2max means that if you improve your fitness from the 25th percentile to the 75th percentile, you might expect your PWV to drop by roughly 0.5–0.8 m/s — enough to reduce your cardiovascular risk by 7–12%.

The HIIT intervention alone did not produce a meaningful group-level change in PWV. Only when blood pressure also dropped (which happened in some but not all participants) did PWV improve. This suggests that for arterial stiffness to reverse, you may need to hit a blood pressure threshold — perhaps a 5–10 mmHg reduction in systolic BP.

**Acknowledged by authors:**

The cross-sectional design cannot establish causality between physical activity and arterial stiffness.

The sample size for the RCT was relatively small (n=79), limiting statistical power to detect small effects.

The 12-week intervention may have been too short to reverse age-related arterial stiffening.

The study only examined HIIT, not other exercise modalities.

**Critical reader observations:**

**Selection bias:** The HA group was exceptionally fit (VO2max 42.6 ml/min/kg at age 60 — equivalent to a 30-year-old in good shape). They are not representative of typical active older adults. This makes the cross-sectional comparison less generalizable.

**Confounding by healthy lifestyle:** The HA group likely differed in many ways beyond exercise — diet, sleep, stress, socioeconomic status, genetics. These were not controlled for.

**The "healthy sedentary" group was not truly sedentary:** They averaged 10,222 steps/day, which exceeds the typical 5,000–7,000 steps of a sedentary person. This blurs the distinction between groups.

**No intention-to-treat analysis reported:** Dropouts and adherence were not clearly described.

**No adjustment for multiple comparisons:** They tested many outcomes (PWV, blood pressure, fitness, blood markers) without correcting for the increased risk of false positives.

**Industry funding:** Not explicitly stated, but the study was conducted at a university — no obvious pharmaceutical or device company involvement.

**Lack of blinding for participants and most researchers:** The control group received no placebo or attention, so any observed effects could be partly due to the social contact and attention of supervised exercise sessions.

**The simple randomization method (drawing from envelope) is outdated and prone to manipulation.**

For someone running their own n=1 experiment:

**What to test:**

Test whether high-intensity interval training (4 × 4 minutes at 85–95% max heart rate, 3×/week) can reduce your arterial stiffness over 12 weeks.

Alternatively, test whether any exercise that lowers your resting blood pressure by at least 5–10 mmHg will also reduce arterial stiffness.

For a longer-term experiment (6–12 months), test whether consistent moderate-to-vigorous exercise (150+ minutes/week) can maintain or improve arterial stiffness compared to a sedentary period.

**Minimum meaningful duration:**

12 weeks is the minimum to see any change in PWV, but this study suggests it may not be enough for everyone. A more realistic minimum is 6 months, and optimal is 1+ years of consistent training.

For the cross-sectional benefit (lifelong exercise keeping arteries young), you're looking at years to decades of regular activity.

**What to measure (specific metrics):**

**Primary metric:** Pulse wave velocity (PWV). This requires specialized equipment (SphygmoCor or similar) typically found in university labs or cardiology clinics. Some health clinics offer it for ~$50–100 per measurement.

**Alternative metric:** If PWV is unavailable, measure resting blood pressure (especially 24-hour ambulatory BP if possible). A sustained reduction of 5–10 mmHg in systolic BP is a reasonable proxy.

**Secondary metrics:** VO2max (via a fitness test or estimated from a submaximal test like the Cooper 12-minute run), resting heart rate, body weight, waist circumference.

**Measure at baseline, then every 4–8 weeks during the intervention.**

**Key confounds to control for:**

**Timing of measurements:** Always measure PWV in the morning, after fasting, after 10 minutes supine rest, and after avoiding exercise for 24 hours and alcohol/caffeine for 12 hours. This is critical — PWV varies throughout the day and after meals/exercise.

**Blood pressure medications:** If you take antihypertensives, do not change your dose during the experiment. Some BP drugs directly affect arterial stiffness independent of exercise.

**Diet:** High-sodium meals, alcohol, and caffeine can acutely increase PWV. Keep your diet consistent on measurement days.

**Sleep:** Poor sleep increases arterial stiffness. Track sleep quality and duration.

**Stress:** Psychological stress raises blood pressure and PWV. Note major stressors.

**Seasonal effects:** PWV may be higher in winter. If your experiment spans seasons, this could confound results.

**Hydration status:** Dehydration can affect PWV. Stay well-hydrated before measurements.

**What a positive result would look like:**

A reduction in PWV of at least 0.5 m/s after 12 weeks (the minimal clinically important difference).

A reduction in resting systolic blood pressure of at least 5 mmHg.

An increase in VO2max of at least 3–5 ml/min/kg (roughly 10–15% improvement).

Ideally, all three moving in the right direction simultaneously.

**Important caveat from this study:** If your blood pressure does NOT drop with exercise, don't expect your PWV to improve either —